drugset / Trial / NCT00219843
Intralesional PV-10 Chemoablation of Metastatic Melanoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The objective of this study is to investigate the safety of intralesional (IL) PV-10 for the treatment of metastatic melanoma. This study will also include a preliminary assessment of response of treated and untreated lesions by clinical evaluation at follow-up of 12 to 24 weeks following IL PV-10 treatment.
Timeline
- Start
- 2005-08
- Primary completion
- —
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PV-10 | Unknown | 10 % | Other |